6/5/2026 4:57:37 PM Skinny labelling after Hikma v Amarin: active inducement in the US Supreme Court By Amy Howlett On 4 June 2026, the US Supreme Court handed down its judgment in Hikma Pharmaceuticals v Amarin Pharma, finding that Amarin Pharma...
6/5/2026 9:49:34 AM Life Sciences disputes: navigating causation and damages in an uncertain world By Francion Brooks As part of London International Disputes Week 2026, Bristows and Oxera hosted a discussion on causation, counterfactuals and damages in...
4/17/2026 10:00:23 AM Ten takeaways from the EDPB's draft guidelines on scientific research By Hannah Crowther I have now waded through all 66 pages of the European Data Protection Board’s draft guidelines on scientific research, and here’s a...
4/15/2026 2:12:07 PM A new chapter for Women’s Health: Reform, funding and opportunity By Anna Honey The UK government published a renewed Women’s Health Strategy for England today, signalling a continued push to address long-standing...
3/24/2026 2:09:36 PM Biotech Review of the Year Issue 13 - out now! By Charlie French Ellen Lambrix Aida Tohala Erik Müürsepp +1 more... Show less We’re pleased to share the 13th edition of our Biotech Review of the Year, bringing together practical legal, regulatory and commercial...
3/24/2026 1:47:23 PM Competition authorities in Europe target ‘killer acquisitions’ – what biotech companies need to know By Sophie Lawrance Victoria Yuan This article is part of our Biotech Review of the Year - Issue 13 publication. Competition authorities are increasingly targeting...
2/16/2026 9:14:09 AM Women’s Health in focus: key themes for 2026 By Laura Harwood Ellie Handy The women’s health sector is undergoing significant transformation. A major driving force for this is the evolution of AI and the impact...
1/28/2026 4:35:53 PM A forensic dissection of revised classification Rule 11 – is there any basis for expecting software down classification? By Ellie Handy At the time the Commission published its “Proposal for a regulation to simplify rules on medical and in vitro diagnostic devices”, making...
1/16/2026 2:38:37 PM Medical device simplification in detail: orphan and breakthrough device designations By Jamie Hatzel We wrote recently about the European Commission’s proposals to simplify the EU Medical Device Regulation (“MDR”)[1] and EU In Vitro...
1/16/2026 1:35:54 PM What Top 10 EU And UK Life Sciences Regulatory developments are we following in 2026? By Xisca Borrás There is so much legislative change in the EU and UK in the life sciences sector at the moment that it is sometimes difficult to keep up...
12/22/2025 10:30:42 AM Podcast: Navigating Femtech regulatory compliance in the EU – A legal conversation By Xisca Borrás Ellie Handy Those working in the Femtech space have a difficult regulatory framework to navigate in the EU. For products that qualify as a medical...
12/19/2025 1:34:38 PM The EU pharma package: what we know and what to expect By Xisca Borrás After years in the making, the much-awaited political agreement reached by the EU institutions on the so-called “EU pharma package” will...